These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16137634)

  • 61. Label-Free Confocal Raman Mapping of Transportan in Melanoma Cells.
    Cosme PJ; Ye J; Sears S; Wojcikiewicz EP; Terentis AC
    Mol Pharm; 2018 Mar; 15(3):851-860. PubMed ID: 29397737
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Direct effects of low-frequency acoustic oscillations on cell membranes].
    Svidovyĭ VI
    Med Tr Prom Ekol; 1996; (9):29-32. PubMed ID: 9019329
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Peptide toxicity prediction.
    Gupta S; Kapoor P; Chaudhary K; Gautam A; Kumar R; Raghava GP
    Methods Mol Biol; 2015; 1268():143-57. PubMed ID: 25555724
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison of cationic and amphipathic cell penetrating peptides for siRNA delivery and efficacy.
    Mo RH; Zaro JL; Shen WC
    Mol Pharm; 2012 Feb; 9(2):299-309. PubMed ID: 22171592
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cell-penetrating peptides: design, synthesis, and applications.
    Copolovici DM; Langel K; Eriste E; Langel Ü
    ACS Nano; 2014 Mar; 8(3):1972-94. PubMed ID: 24559246
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mechanisms of cellular uptake of cell-penetrating peptides.
    Madani F; Lindberg S; Langel U; Futaki S; Gräslund A
    J Biophys; 2011; 2011():414729. PubMed ID: 21687343
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Penetratin story: an overview.
    Dupont E; Prochiantz A; Joliot A
    Methods Mol Biol; 2011; 683():21-9. PubMed ID: 21053119
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cargo-dependent cytotoxicity and delivery efficacy of cell-penetrating peptides: a comparative study.
    El-Andaloussi S; Järver P; Johansson HJ; Langel U
    Biochem J; 2007 Oct; 407(2):285-92. PubMed ID: 17627607
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cell-Penetrating Peptides: From Basic Research to Clinics.
    Guidotti G; Brambilla L; Rossi D
    Trends Pharmacol Sci; 2017 Apr; 38(4):406-424. PubMed ID: 28209404
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Chemical strategies for antisense antibiotics.
    Pals MJ; Lindberg A; Velema WA
    Chem Soc Rev; 2024 Oct; ():. PubMed ID: 39436264
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Intracellular delivery of antiviral shRNA using penetratin-based complexes effectively inhibits respiratory syncytial virus replication and host cell apoptosis.
    Faghirabadi F; Abuei H; Malekzadeh MH; Mojiri A; Farhadi A
    Virol J; 2024 Sep; 21(1):235. PubMed ID: 39350281
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Beyond Transduction: Anti-Inflammatory Effects of Cell Penetrating Peptides.
    Lopuszynski J; Wang J; Zahid M
    Molecules; 2024 Aug; 29(17):. PubMed ID: 39274936
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Rational fusion design inspired by cell-penetrating peptide: SS31/S-14 G Humanin hybrid peptide with amplified multimodal efficacy and bio-permeability for the treatment of Alzheimer's disease.
    Qian K; Yang P; Li Y; Meng R; Cheng Y; Zhou L; Wu J; Xu S; Bao X; Guo Q; Wang P; Xu M; Sheng D; Zhang Q
    Asian J Pharm Sci; 2024 Aug; 19(4):100938. PubMed ID: 39253611
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Endosomal escape: A bottleneck for LNP-mediated therapeutics.
    Chatterjee S; Kon E; Sharma P; Peer D
    Proc Natl Acad Sci U S A; 2024 Mar; 121(11):e2307800120. PubMed ID: 38437552
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Toxicity Studies of Cardiac-Targeting Peptide Reveal a Robust Safety Profile.
    Sahagun DA; Lopuszynski JB; Feldman KS; Pogodzinski N; Zahid M
    Pharmaceutics; 2024 Jan; 16(1):. PubMed ID: 38258084
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Enhancing Antisense Oligonucleotide-Based Therapeutic Delivery with DG9, a Versatile Cell-Penetrating Peptide.
    Haque US; Yokota T
    Cells; 2023 Oct; 12(19):. PubMed ID: 37830609
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pharmacokinetics, biodistribution and toxicology of novel cell-penetrating peptides.
    Reveret L; Leclerc M; Morin F; Émond V; Calon F
    Sci Rep; 2023 Jul; 13(1):11081. PubMed ID: 37422520
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Transportan 10 Induces Perturbation and Pores Formation in Giant Plasma Membrane Vesicles Derived from Cancer Liver Cells.
    Anselmo S; Sancataldo G; Baiamonte C; Pizzolanti G; Vetri V
    Biomolecules; 2023 Mar; 13(3):. PubMed ID: 36979427
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Choosing an Optimal Solvent Is Crucial for Obtaining Cell-Penetrating Peptide Nanoparticles with Desired Properties and High Activity in Nucleic Acid Delivery.
    Biswas A; Maloverjan M; Padari K; Abroi A; Rätsep M; Wärmländer SKTS; Jarvet J; Gräslund A; Kisand V; Lõhmus R; Pooga M
    Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839718
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.